New/emerging psychoactive substances and associated psychopathological consequences
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Abstract
Background: The present paper provides an updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification of those NPS being commented in specialised online sources and the related short-/long-term psychopathological and medical ill-health effects. Methods: NPS have been identified through an innovative crawling/navigating software, called the ‘NPS.Finder®’, created in order to facilitate the process of early recognition of NPS online. A range of information regarding NPS, including chemical and street names; chemical formula; three-dimensional image and anecdotally reported clinical/psychoactive effects, were here made available. Results: Using the ‘NPS.Finder®’ approach, a few thousand NPS were here preliminarily identified, a number which is about 4-fold higher than those figures suggested by European and international drug agencies. NPS most commonly associated with the onset of psychopathological consequences included here synthetic cannabinoids/cannabimimetics; new synthetic opioids; ketamine-like dissociatives; novel stimulants; novel psychedelics and several prescription and over-the-counter medicines. Conclusions: The ever-increasing changes in terms of recreational psychotropics' availability represent a relatively new challenge for psychiatry, as the pharmacodynamics and pharmacokinetics of many NPS have not been thoroughly understood. Health/mental health professionals should be informed about the range of NPS; their intake modalities; their psychoactive sought-after effects; the idiosyncratic psychotropics' combinations and finally, their medical and psychopathological risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Indeed, when tapering down a therapeutic dosage AD, symptoms most typically are both mild/go untreated; and resolve spontaneously (21).”
From Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs (2020) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liking, wanting, and the incentive-sensitization theory of addiction
Berridge, K. C., & Robinson, T. E. (2016) · American Psychologist · doi:10.1037/amp0000059 · Cited by 1,440
Handbook of experimental pharmacology
(1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90023-5 · Cited by 1,417
European Monitoring Centre for Drugs and Drug Addiction
Anderson, M. (2014) · European Union regulations | European Encyclopedia of law · Cited by 1,213
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 710
The Toxicology of Bath Salts: A Review of Synthetic Cathinones
Prosser, J. M., & Nelson, L. S. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0193-z · Cited by 705
Pharmacological characterization of designer cathinones in vitro
Simmler, L., Buser, T., Donzelli, M., Schramm, Y., Dieu, L., Huwyler, J., Chaboz, S., Hoener, M., & Liechti, M. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02145.x · Cited by 672
Hermanns‐Clausen, M., Kneisel, S., Szabo, B., & Auwärter, V. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04078.x · Cited by 479
A review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Hajak, G., Müller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00491.x · Cited by 404 · cited 1×
“Zolpidem and zopiclone seem to be the most involved in the diversion and abuse phenomena ([ACMD], 2013), and it is likely that the misusing phenomenon is currently underestimated (Hajak et al., 2003).”
BackgroundTait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016) · Clinical Toxicology · doi:10.3109/15563650.2015.1110590 · Cited by 378
Research works printed but not linked: 9
- 2018, Analysis of Drug Markets: Opiates, Cocaine, Cannabis, Synthetic Drugs
- Lovrecic, B and Lovrecic, M (2017) Novel psychoactive synthetic cannabinoids and synthetic cathinones: the never-ending story of potential clinical toxicity. Heroin Addiction and Related Clinical Problems. Available at https://www.researchgate.net/profile/Barbara_Lovrecic/publication/319554544_Novel_psychoactive_synthetic_cannabinoids_and_synthetic_cathinones_The_never-ending_story_of_potential_clinical_toxicity/links/59b3c8a70f7e9b37435210fb/ (Accessed 13 October 2018).
- Cheng, 2012, Bath salts and synthetic cannabinoids: a review, American Academy of Emergency Medicine, 19, 19
- 2018, World Drug Report 2018 Volume 3 – Analysis of Drug Markets: Opiates, Cocaine, Cannabis, Synthetic Drugs
- 2013, The Challenge of New Psychoactive Substances: A Report from the Global SMART Programme
- Denysenko, 2015, Catatonia in medically ill patients an evidence-based medicine (EBM) monograph for psychosomatic medicine practice, The European Association of Psychosomatic Medicine, 30, 140
- 2017, High Risk Drug use and New Psychoactive Substances. EMCDDA Rapid Communication
- Corkery, 2018, Handbook of Novel Psychoactive Substances – What Clinicians Should Know About NPS, 181
- Sutherland, 2016, New (and Emerging) Psychoactive Substances (NPS)
Cited by
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
Sharif, S., Guirguis, A., Fergus, S., & Schifano, F. (2021) · Brain Sciences · doi:10.3390/brainsci11030355 · Cited by 166
Self-citationAn updated review on synthetic cathinones
Soares, J., Costa, V. M., Bastos, M. D. L., Carvalho, F. D., & Capela, J. P. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03083-3 · Cited by 133
Substance-related exogenous psychosis: a postmodern syndrome
Martinotti, G., Risio, L. D., Vannini, C., Schifano, F., Pettorruso, M., & Giannantonio, M. D. (2020) · CNS Spectrums · doi:10.1017/s1092852920001479 · Cited by 111
Self-citationNew Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
Chiappini, S., Mosca, A., Miuli, A., Santovito, M. C., Orsolini, L., Corkery, J., Guirguis, A., Pettorruso, M., Martinotti, G., Giannantonio, M. D., et al. (2021) · Medicina · doi:10.3390/medicina57060580 · Cited by 105
Self-citationSynthetic Cathinones and Neurotoxicity Risks: A Systematic Review
Daziani, G., Faro, A. F. L., Montana, V., Goteri, G., Pesaresi, M., Bambagiotti, G., Montanari, E., Giorgetti, R., & Montana, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076230 · Cited by 80
Metadata
- Authors
- Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A.
- Affiliations
- University of Hertfordshire (GB)
- Homerton University Hospital (GB)
- Swansea University (GB)
- Camden and Islington NHS Foundation Trust (GB)
- ASL Roma (IT)
- University of Duisburg-Essen (DE)
- Marconi University (IT)
- Corresponding author
- Chiappini, S.
- ORCID
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2019-07-22
- Volume
- 51
- Issue
- 1
- Pages
- 30-42
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2957505335
- Cited by
- 119
- References
- 126
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 18 · 2023: 14 · 2022: 15 · 2021: 22 · 2020: 14 · 2019: 4
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-07-22)
- Open access
- green
- hdl.handle.net
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Hertfordshire Research Archive (University of Hertfordshire) (acceptedVersion)
- University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- new psychoactive substances, synthetic cannabinoids, synthetic opioids, prescription drug misuse, psychopathological consequences, recreational drug use, mental health risk
- MeSH terms
- Recreational Drug Use, Humans, Psychopathology, Psychotropic Drugs, Illicit Drugs, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New/emerging psychoactive substances and associated psychopathological consequences. https://app.cochat.ai/papers/10.1017/s0033291719001727
- The paper
- Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021). New/emerging psychoactive substances and associated psychopathological consequences. Psychological Medicine. https://doi.org/10.1017/s0033291719001727
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.